Cetuximab

  • Web西妥昔单抗；妥西单抗；妥昔单克隆抗体

Web Definition

1.
西妥昔单抗
西妥昔单抗 (Cetuximab)，商品名称艾比特思(Erbitux)，是重组人鼠嵌合的IgG1单克隆抗体。于2004年2月12日获得美国食品和 …
baike.baidu.com|Based on 835 pages
2.
妥西单抗
...imatinib） ; ③EGFR单克隆抗体，如西妥西单抗（cetuximab） .
feiai.cn-cancer.com|Based on 15 pages
3.
妥昔单克隆抗体
...振技术的 BIAcore 3000 系统研究国产西妥昔单克隆抗体（cetuximab ）C225 与可溶 性重组人表皮生长因子受体（EGFR ） …
wenku.baidu.com|Based on 6 pages
4.
必得舒
以尔必得舒(Cetuximab)并用铂帝尔(Cisplatin)、欧洲紫杉醇(Decetaxel)以及五-氟二氧嘧啶(5-FU)的诱导化疗治疗局部晚期口腔 …
www.totalcare.org.tw|Based on 4 pages
5.
标靶治疗
最近有研究显示利用同步的标靶治疗（cetuximab）加上放疗后，后期头颈癌的复发率可减少三成而没有增加毒性。我们正期待 …
news.hkheadline.com|Based on 3 pages

Sample Sentence

Definition:
AllAll,西妥昔单抗西妥昔单抗,妥西单抗妥西单抗,妥昔单克隆抗体妥昔单克隆抗体
Category:AllAll,OralOral,WrittenWritten,TitleTitle,TechnicalTechnical
Source:AllAll,DictionaryDictionary,WebWeb
Difficulty:AllAll,EasyEasy,MiddleMiddle,HardHard
1.
The new study aimed to see if addition of the drug cetuximab, also known as Erbitux, would help patients even more.
最新的研究看出如果加用西妥昔单抗（又名爱比妥）可以明显增加这种手术切除的优势。
zuì xīn de yán jiū kàn chū rú guǒ jiā yòng xī tuǒ xī dān kàng ( yòu míng ài bǐ tuǒ ) kě yǐ míng xiǎn zēng jiā zhè zhǒng shǒu shù qiē chú de yōu shì 。
news.dxy.cn
2.
Objective As EGFR inhibitor, Cetuximab has been widely used in several solid tumors, and has perfect therapeutic effect and security.
目的作为EGFR抑制剂，西妥昔单抗在多种实体瘤中应用日益广泛，显示出良好的疗效和安全性。
mù dì zuò wéi EGFR yì zhì jì , xī tuǒ xī dān kàng zài duō zhǒng shí tǐ liú zhōng yìng yòng rì yì guǎng fàn , xiǎn shì chū liáng hǎo de liáo xiào hé ān quán xìng 。
fabiao.net
3.
Biopsies and plasma samples were taken before treatment, after cetuximab but before CRT, and at the time of surgery.
治疗前先行活组织检查和血浆样本的采集，西妥昔单抗应用之前，CRT之前，即手术的时机。
zhì liáo qián xiān xíng huó zǔ zhī jiǎn chá hé xuè jiāng yàng běn de cǎi jí , xī tuǒ xī dān kàng yìng yòng zhī qián , CRT zhī qián , jí shǒu shù de shí jī 。
news.dxy.cn
4.
The use of cetuximab for colorectal cancer was highest in France and the United States and lowest in Finland.
法国及美国应用西妥昔单抗治疗直肠结肠癌最多，而芬兰最低。
fǎ guó jí měi guó yìng yòng xī tuǒ xī dān kàng zhì liáo zhí cháng jié cháng ái zuì duō , ér fēn lán zuì dī 。
www.med66.com
5.
The use of bevacizumab (as well as cetuximab) for maintenance remains unproven, however.
贝伐单抗（以及西妥昔单抗）对维持治疗仍无提高。
bèi fá dān kàng ( yǐ jí xī tuǒ xī dān kàng ) duì wéi chí zhì liáo réng wú tí gāo 。
news.dxy.cn
6.
In these patients, severe hypomagnesaemia recurs rarely within 2 months from the start of cetuximab rechallenge.
这些病人中，西妥昔单抗二次给药两个月内复发严重低镁血症的极少。
zhè xiē bìng rén zhōng , xī tuǒ xī dān kàng èr cì gěi yào liǎng gè yuè nèi fù fā yán zhòng dī měi xuè zhèng de jí shǎo 。
www.med66.com
7.
We previously showed that KRAS mutations were associated with resistance to cetuximab in 30 CRC patients.
我们之前研究显示：KRAS突变与30个CRC患者对西妥昔单抗耐药有关。
wǒ men zhī qián yán jiū xiǎn shì : KRAS tū biàn yǔ sān shí gè CRC huàn zhě duì xī tuǒ xī dān kàng nài yào yǒu guān 。
hulan8.com
8.
EMEA, the European Medicines Agency, has already restricted use of cetuximab and panitumumab to such patients.
欧洲药品局EMEA已经限制西妥昔单抗和帕尼单抗在这些患者使用。
ōu zhōu yào pǐn jú EMEA yǐ jīng xiàn zhì xī tuǒ xī dān kàng hé pà ní dān kàng zài zhè xiē huàn zhě shǐ yòng 。
news.dxy.cn
9.
based on favourable time-to-progression (TTP) and response-rate outcomes from the Bowel Oncology with Cetuximab Antibody (BOND) study.
基于有利的，从西妥昔单抗治疗肠肿瘤的研究得出，时间-进程（TTP）的和应答率的结果。
jī yú yǒu lì de , cóng xī tuǒ xī dān kàng zhì liáo cháng zhǒng liú de yán jiū dé chū , shí jiān - jìn chéng ( TTP ) de hé yìng dá lǜ de jié guǒ 。
www.med66.com
10.
But these drugs called EGFR inhibitors, such as cetuximab, have not been very effective against colon cancer.
但这些称为EGFR抑制因子如西妥昔单抗的药物对结肠癌的治疗还不是很有效。
dàn zhè xiē chēng wéi EGFR yì zhì yīn zǐ rú xī tuǒ xī dān kàng de yào wù duì jié cháng ái de zhì liáo hái bú shì hěn yǒu xiào 。
news.dxy.cn